Actavis, Inc. (extinct)

Actavis, Inc. (extinct)

Actavis, Inc. (extinct)

Overview
Date Founded

1983

Headquarters

Morris Corporate Center III,400 Interpace Parkway,Parsippany, NJ 07054

Type of Company

Private

Employees (Worldwide)

1,001 - 5,000

Industries

Pharmaceuticals
Consumer Services
Hospitals & Patient Services
Wholesale: Consumer Non-Durables/Sundries
Biotechnology

Company Description

Actavis, Inc. is a pharmaceutical company. It focuses on the development and distribution of generic products. The company engages in developing, manufacturing and marketing generic, branded generic, legacy brands and over-the-counter products. It operates its business in three segments: Actavis Pharma, Actavis Specialty Brands and Distribution. The Actavis Pharma segment develops and out-licenses generic pharmaceutical products outside the U.S. through its medis third-party business. The Actavis Specialty Brands segment engages in developing and marketing biosimilars products in women's health, oncology and other therapeutic categories. The Distribution segment distributes generic, select brand pharmaceutical products, vaccines, injectables and over-the-counter medicines from suppliers to independent pharmacies, alternate care providers, pharmacy chains and physicians offices. The company was founded by Allen Y. Chao and David C. Hsia in 1984 and is headquartered in Parsippany, NJ.

Contact Data
Trying to get in touch with decision makers at Actavis, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Paths to Actavis, Inc.
Potential Connections via
Relationship Science
You
Actavis, Inc.
Recent Transactions
Details Hidden

Actavis, Inc. purchases Warner Chilcott Plc resulting in a new company Allergan Plc

Details Hidden

Vivimed Labs Ltd. purchases Actavis Pharma Manufacturing Pvt Ltd. from Actavis, Inc.

Details Hidden

Actavis, Inc. purchases Comprehensive Clinical Development Inc /Early Development Div from Comprehensive Clinical Development, Inc.

Transaction Advisors
Legal Advisor

Advised onActavis, Inc. purchases Warner Chilcott Plc resulting in a new company Allergan Plc

Accountant

Advised onActavis, Inc. purchases Schein Pharmaceutical, Inc.

Investment Advisor

Advised onActavis, Inc. purchases Schein Pharmaceutical, Inc.

Chair, Corporate Department

Advised onActavis, Inc. purchases Warner Chilcott Plc resulting in a new company Allergan Plc

Head, Antitrust & Competition Practice

Advised onActavis, Inc. purchases Warner Chilcott Plc resulting in a new company Allergan Plc

Legal Advisor

Advised onActavis, Inc. purchases Warner Chilcott Plc resulting in a new company Allergan Plc

Advisors & Consultants
Legal Advisor

Chair, Benefits & Compensation Practice at Latham & Watkins LLP

Legal Advisor

Shareholder at Greenberg Traurig LLP

Real Estate Agent

President & Managing Director, NYC Operations at Avison Young (Canada), Inc.

Clients

Meda AB engages in the research, development, manufacture, and sale of pharmaceutical and medical products. It offers respiratory, dermatology, pain and inflammation, consumer healthcare, and over-the-counter products. The company was founded by Gert Lennart Perlhagen in 1999 and is headquartered in Solna, Sweden.

Non-Profit Donations & Grants
Political Donations
$250
2011
$500
2011
$500
2011
Investments
Details Hidden

moksha8 Pharmaceuticals, Inc. operates as a pharmaceutical company. It's products include viibryd, razapina, queopine, benexafrina, arasid, ziledon, zopina, and rispalum. The firm offers a portfolio of therapeutics for bipolar disorders and schizophrenia. The company was founded by Balkrishan Gill in 2007 and is headquartered in Berwyn, PA.

Investors
Details Hidden

Chairman & Founder at Novator ehf

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Actavis, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Actavis, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Actavis, Inc..